Cargando…

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease

Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is...

Descripción completa

Detalles Bibliográficos
Autor principal: Antonini, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Movement Disorder Society 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027699/
https://www.ncbi.nlm.nih.gov/pubmed/24868344
http://dx.doi.org/10.14802/jmd.09002
_version_ 1782316985726533632
author Antonini, Angelo
author_facet Antonini, Angelo
author_sort Antonini, Angelo
collection PubMed
description Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is limited by compliance, mostly injection site skin reactions. Administration of levodopa/carbidopa by continuous duodenal infusion allows replacement of all oral medications and permits achievement of a satisfactory therapeutic response paralleled by a reduction in motor complication severity. However, this procedure is more invasive than apomorphine as it requires a percutaneous endoscopic gastrostomy Clinical experience with infusions shows that continuous dopaminergic stimulation of dopaminergic medications reduces dyskinesia and widens the therapeutic window in advanced PD.
format Online
Article
Text
id pubmed-4027699
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher The Korean Movement Disorder Society
record_format MEDLINE/PubMed
spelling pubmed-40276992014-05-27 Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease Antonini, Angelo J Mov Disord Invited Review Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is limited by compliance, mostly injection site skin reactions. Administration of levodopa/carbidopa by continuous duodenal infusion allows replacement of all oral medications and permits achievement of a satisfactory therapeutic response paralleled by a reduction in motor complication severity. However, this procedure is more invasive than apomorphine as it requires a percutaneous endoscopic gastrostomy Clinical experience with infusions shows that continuous dopaminergic stimulation of dopaminergic medications reduces dyskinesia and widens the therapeutic window in advanced PD. The Korean Movement Disorder Society 2009-05 2009-04-30 /pmc/articles/PMC4027699/ /pubmed/24868344 http://dx.doi.org/10.14802/jmd.09002 Text en Copyright © 2009 The Korean Movement Disorder Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Invited Review
Antonini, Angelo
Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_full Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_fullStr Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_full_unstemmed Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_short Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_sort apomorphine and levodopa infusion therapies for advanced parkinson’s disease
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027699/
https://www.ncbi.nlm.nih.gov/pubmed/24868344
http://dx.doi.org/10.14802/jmd.09002
work_keys_str_mv AT antoniniangelo apomorphineandlevodopainfusiontherapiesforadvancedparkinsonsdisease